10:03 AM EDT, 09/19/2025 (MT Newswires) -- InterCure ( INCR ) said Friday it has agreed to acquire medical cannabis brand and technology company Botanico, also known as ISHI, in a two-phase deal valued at about 10% of InterCure's ( INCR ) outstanding shares on a fully-diluted basis.

InterCure ( INCR ) will initially acquire 50% of ISHI for nearly 2.5 million ordinary shares, with the remaining half to be purchased later for an additional consideration of nearly 2.5 million shares. The final tranche will close once ISHI posts three months of operating profitability or within 24 months of the initial closing, the company said.

The transaction, which is expected to close in Q1 of 2026 pending regulatory approvals in Israel, will transfer ISHI's cultivation technologies and brand partnerships with leading US cannabis operators, to InterCure ( INCR ).

As part of the deal, ISHI's founders, Chief Executive Omer Layani and Chief Operating Officer Dor Hershkovitz, will join InterCure's ( INCR ) leadership team, the company said.

Shares of InterCure ( INCR ) were up 0.9% in recent Friday trading.

Price: 1.50, Change: +0.01, Percent Change: +0.92